Day 3 - Wednesday 17th JuneWednesday, 17 June 2026 - CEST Time Zone

• Exploring the evolving role of clinical evidence in the medical device lifecycle, from development to post-market surveillance, and its impact on regulatory compliance.
• Discussing innovative approaches to generating, managing, and leveraging clinical data to meet the increasing demands of global regulatory bodies.
• Looking into future trends, challenges, and opportunities in clinical evidence generation to support device safety, efficacy, and market success.

For more information, please contact Neha Singh at niha.singh@informa.com

• Examine the latest updates in clinical evaluation requirements for medical device recertification, focusing on leveraging post-market surveillance (PMS) data.
• Discuss strategies for effectively utilizing 5 years of PMS data to demonstrate ongoing compliance and device safety.
• Insights into best practices for integrating PMS findings into clinical evaluation reports to streamline the recertification process.

• Exploring innovative tools, technologies, and methodologies shaping the future of PMS to ensure compliance and improve patient safety.
• Perspectives on regulatory expectations and best practices for implementing a forward-thinking PMS strategy.

For more information, please contact Neha Singh at niha.singh@informa.com

• Diving into current challenges and opportunities in aligning PMS practices with UK-specific regulatory requirements
• Exploring future trends and strategies for navigating the UK regulatory landscape while ensuring robust PMS compliance